Empowering dialysis users and caregivers
Search for dialysis centres here
Log in to explore the world's most comprehensive database of dialysis centres for free!
Professional dialysis recruitment| immatics to Receive Support From Pfizer for its Pivotal Phase III Study ... - DigitalJournal.com (press release) |
 |
 |
|
DigitalJournal.com (press release) The pivotal Phase III study will evaluate as the primary endpoint the overall survival of advanced renal cell carcinoma patients treated with IMA901 in combination with Pfizer's Sutent(R) (sunitinib malate) versus Sutent(R) alone. |
